The edition · Pulmonology
Adaptive D-dimer cut-offs ruled out pulmonary embolism safely, even above 500
A meta-analysis of 12,194 prospectively managed patients found age- and probability-adjusted D-dimer thresholds missed very few emboli; mucus plugs on CT predicted exacerbations and new COPD in people with normal spirometry; and intermittently raised eosinophils still marked mepolizumab responders in COPD.
The edition in brief
Six prospective management studies of 12,194 patients with suspected pulmonary embolism, in which age-adjusted or clinical probability-adjusted D-dimer thresholds decided who had CT pulmonary angiography, showed a pooled 3-month failure rate of 0.12% when PE was excluded without imaging, and 0.50% in the adaptive window between 500 ng/mL and the adjusted cut-off. In a Chinese community cohort of 1,939 adults, three or more CT mucus plugs in people with preserved spirometry were associated with more exacerbations and a higher risk of developing spirometric COPD (18.2% vs 7.6%). A pooled analysis of three mepolizumab trials in COPD found benefit in patients with eosinophils of 300 cells/µL or more at any point in the prior year, including variable counts, but none in those persistently below 150. The PASSAGE real-world study found tezepelumab associated with 70% fewer asthma exacerbations across phenotypes. And China's Clean Heating Policy, which replaced household coal, was associated with a 7.5-point fall in the prevalence of respiratory symptoms.
Three or more CT mucus plugs predicted exacerbations and new COPD in people with normal spirometry
Mucus plugs on CT in someone with normal spirometry signal a higher risk of exacerbations and future COPD — follow them up.
Mepolizumab helped COPD patients whose eosinophils were high at any point — not only persistently
In COPD, a single raised eosinophil count in the past year still identifies patients who may benefit from mepolizumab; persistently low counts predict no benefit.
Tezepelumab in real-world severe asthma: exacerbations fell 70% across phenotypes
Tezepelumab reduced exacerbations substantially in real-world severe asthma, including low-eosinophil phenotypes, though without a control group.
Replacing household coal heating was associated with fewer respiratory symptoms
Removing household coal heating was associated with fewer respiratory symptoms — ask about household fuel in every patient with chronic respiratory complaints.
Calculating the age-adjusted D-dimer
Over 50 with non-high PE probability, use age × 10 ng/mL as the D-dimer cut-off — and always check the laboratory's units.
Adaptive D-dimer thresholds missed PE in about 1 in 200 patients in the window above 500
Adaptive D-dimer thresholds safely exclude PE without imaging, even in patients whose D-dimer is above 500 but below the adjusted cut-off.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for pulmonology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free